All posts by imreal

Healthcare Management Solutions, LLC (HMS) Commemorates Its 20-Year Anniversary with $20,000 Total in Charitable Donations


News Image

We are proud to share some of the fruits of our own 20 years of success with 20 deserving nonprofit organizations. These charitable donations not only amplify the spirit of our work protecting vulnerable populations, they also help make our local communities stronger. -HMS President Leah Heimbach

As Healthcare Management Solutions, LLC (HMS) turns 20 this year, the company has chosen to donate a total of $20,000 — $1,000 each — to 20 amazing charitable organizations that likewise help vulnerable populations who are in need. Thanks to these nonprofits, seniors, veterans, at-risk women and families, plus youth and adults facing homelessness and mental-health challenges — and even defenseless animals — have access to vital support and assistance.

“We are proud to share some of the fruits of our own 20 years of success with 20 deserving nonprofit organizations,” said HMS President Leah Heimbach. “These charitable donations not only amplify the spirit of our work protecting vulnerable populations, they also help make our local communities safer, stronger, and healthier.”

Following are the names, locations, and missions of the 20 organizations selected to receive HMS’ donations:

Milan Puskar Health Right / Friendship House

Morgantown, West Virginia | Website

Founded on the belief that recovery is both possible and probable with the right services and support, this free and charitable clinic offers person-centered, recovery-focused and peer-supported community-based engagement and support for people with mental health concerns and substance misuse challenges.

Health Access, Inc.

Clarksburg, West Virginia | Website

Health Access works to eliminate disparities for those who lack access to basic healthcare. Through Health Access, vulnerable residents in Harrison and Doddridge counties, West Virginia, receive primary and specialty care, prescription medications, cancer screenings, vision, dental, and more, all at no cost.

The Disability Action Center

Fairmont, West Virginia | Website

The Disability Action Center serves as a comprehensive education, training and enrichment center for more than 450 children and adults with disabilities and their families in North Central West Virginia.

Marion County Humane Society

Fairmont, West Virginia | Website

This nonprofit, no-kill animal welfare organization provides quality care for more than 5,000 animals annually.

Hope, Inc Domestic Violence Center

Fairmont, West Virginia | Website

HOPE, Inc., provides resources and services to domestic violence, dating violence, sexual assault, stalking and human tracking victims in Marion, Harrison, Doddridge, Gilmer, and Lewis Counties, ensuring their safety, encouraging self-sufficiency, and promoting lives free of violence.

CASA of Marion County

Fairmont, West Virginia | Website

CASA advocates, educates and promotes the welfare of children in Marion County who have been abused and neglected, by harnessing the talents of community volunteers who ensure the children are provided with safe and permanent homes.

Pet Helpers, Inc

Fairmont, West Virginia | Website

Pet Helpers is a nonprofit, all-volunteer foster network for homeless animals waiting for their forever homes. With no facility or paid staff, all funds go to veterinary care, food, and medications for the animals.

Soup Opera

Fairmont, West Virginia | Website

Serving a daily meal seven days a week, 365 days a year, to 100+ people in need per day in Marion County and surrounding areas, Sobrania, Inc./Soup Opera also provides hygiene products and showers, clothing, blankets, dishes and more as available.

Stepping Stone, Inc.

Fairmont, West Virginia | Website

This community-based treatment facility serves adolescent males (age 14–17) and transitioning adult males (ages 18–21) who are in the custody of the WV DHHR, are victims of abuse/neglect and/or stepped down from higher level treatment/out of state placement, and have disruptive behaviors and emotional distress. The program teaches residents to respect themselves, their community, their parents, police, public officials, adults and their peers.

United Way – Tygart Valley

Fairmont, West Virginia | Website

Tygart Valley United Way improves lives by mobilizing the caring power of communities to better the common good, focusing on education, health and financial stability — the building blocks for a good quality life.

The Op Shop

Fairmont, West Virginia | Website

This not-for-profit community rehabilitation program creates opportunities for adults with disabilities in sheltered or competitive employment. Services include independent living skills, life skills training, job placement, job coaching, work adjustment, and supported employment.

Pressley Ridge

Morgantown, West Virginia | Website

Pressley Ridge provides families and individuals with support and hope, through assistance with foster care and adoption, community-based and in-home services, outpatient services, specialized education, autism services, residential services and transition-age services.

March of Dimes

Arlington, Virginia | Website

March of Dimes has been fighting for the health of moms and babies for 80 years, supporting research, leading programs, and providing education and advocacy so that every family can have the best possible start.

WV Rescues Ministries / Union Mission

Fairmont, West Virginia | Website

Providing physical and spiritual services to those in need in West Virginia through a men’s shelter, women’s and children’s shelter, family shelter, soup kitchen, thrift store and living room, no one is turned away and all have access to hot meals and shelter.

Connecting Link

Fairmont, West Virginia | Website

Connecting Link addresses individuals’ immediate needs in crisis and assists with locating resources for residents of North Central West Virginia, including help with utility termination, prescriptions, transportation, eviction and first month’s rent.

Genesis Youth Crisis Center

Clarksburg, West Virginia | Website

GYCC provides a safe, temporary place for children to stay until permanent placement arrangements can be made.

Bi-County Nutrition Program

Nutter Fort, Salem, and Shinnston, West Virginia | Website

Bi-County provides congregate and home-delivered meals, nutrition education, and referrals for those 60 years and older, their spouses, and their disabled dependent children.

WV Coalition to End Homelessness

Bridgeport, West Virginia | Website

The WV Coalition to End Homelessness assists agencies and communities in West Virginia where homelessness is either a prevalent or a hidden issue, to ensure that no child, veteran, or family enters homelessness in the first place. Housing people is the only way we’ll end homelessness.

The Clarksburg Mission Community

Clarksburg, West Virginia | Website

The Clarksburg Mission provides comfort, reassurance and resources to those in need, including emergency shelter, transitional housing, food, assistance, and more.

Clarksburg Mustard Seed

Clarksburg, West Virginia | Website

Clarksburg Mustard Seed is a food pantry serving people in the community free of charge with food, clothing, cleaning and hygiene items, as well as household items. The pantry also accepts donations for those in need.

About Healthcare Management Solutions, LLC

HMS protects vulnerable populations and veterans. We blend our unique healthcare and technology expertise to create bold, yet cost-effective solutions that federal and state agencies and our private-sector partners need to make sure your loved ones get the best possible care in nursing homes and other healthcare settings, no matter where in America they live.

87% of Gen Z Would Be More Interested in a Job That Pays The Same Day


News Image

With a desire to have more control over their personal finances, the study found that 87% of Gen Z would be more interested in applying for a job that pays them the same day they work.

Instant Financial, the pioneer of fee-free on-demand pay solutions, partnered with the Center for Generational Kinetics, to study the effects and perceptions of wage frequency on the financial security and job requirements of the next wave of young professionals entering the labor market: Generation Z (Gen Z). With a desire to have more control over their personal finances, the study found that 87% of Gen Z would be more interested in applying for a job that pays them the same day they work. And with Gen-Zers set to hold up to 36% of the workforce by the end of this year, employers will need to take note of their demands in order to recruit and retain this generation.

As the generation most likely to switch jobs and land the biggest pay increases, Gen Z is taking advantage of the labor shortage to redefine workplace expectations – much like other areas where these teens and twenty-somethings have pushed the boundaries of cultural norms. In fact, four in ten Gen Z workers would like to leave their job in two years, and behind compensation, mental health and burnout are the top two reasons.

Gen Z Wants More than Money

While compensation is one of the major reasons Gen Z workers leave their current jobs, when it comes to choosing a new job, younger generations are more inclined to take work/life balance into account. And trendy perks or workplace gimmicks aren’t going to cut it – they want to feel like their employers respect them and are willing to invest in their advancement. This means taking their financial security into consideration and helping reduce the stress and anxiety that comes along with living paycheck to paycheck. With only a quarter of Gen Zers saying they can comfortably manage their expenses, it’s not surprising that 62% of Gen Z workers are willing to stay a month to over a year longer at a job if they can get immediate access to their earned pay after each day’s work at no cost, the highest of any generation. Furthermore, 61% of Gen Z respondents said they would be less likely to be late on bills if they had access to their earned wages after each day’s work.

”Gen Z isn’t going to sit at home while they wait two weeks for a paycheck so they can pay their bills,” said Tal Clark, CEO of Instant Financial. “Our research shows if they need money before payday, they are the generation most likely to take on a short term job that pays immediately, and also the most likely to work more shifts or hours at their current job if they have access to their wages after every day’s work. After all, they are the on-demand generation. Why should their salaries be any different?”

Responsible Earned Wage Access

But immediate access to their earned wages isn’t enough. In fact, with 94% of Gen Z workers saying it is unfair to be charged a fee to access their earned pay after a day of work, it’s clear that in order to recruit and retain younger workers, employers will need to implement a responsible earned wage access (EWA) program that allows employees to get paid their earned wages at the end of every work day, free of fees.

To meet the demands of millions of Gen Z employees and their employers across the country, Instant Pay is the only on-demand pay solution that gives employees access to their earned wages, free of predatory fees. For more information on how your company can utilize a responsible, earned wage access program to attract the youngest workers entering the workforce, visit http://www.instant.co.

About the Study

The survey of 1,000 employed full-time or part-time US labor force participants, aged 16-55, was conducted by the Center for Generational Kinetics from April 9, 2022, to April 20, 2022. The margin of error is +/-3.1 percentage points.

To download a copy of the Wages and Wellbeing study from Instant Financial, visit https://www.instant.co/resource/earned-wage-study/.

About Instant Financial

Instant Financial is leading the charge to provide financial freedom and wellness to millions of workers in the United States through its earned wage access solutions. By enabling employers to allow employees to access their daily wages immediately after their shift, Instant Financial helps organizations improve retention and reduce absenteeism while helping employees take control of their financial freedom by bridging the gap between work day and payday. Learn more about Instant Financial at http://www.instant.co.

About Center of Generational Kinetics

The Center for Generational Kinetics, LLC (CGK) is the leading research, advisory, and speaking firm focused on uncovering key emerging trends, generational change, and behavioral insights. CGK’s team leads original research around the world to solve important consumer and workforce challenges. The firm uncovers new and unexpected, statistically accurate insights for innovative, market-leading clients. CGK’s team has worked with over 700 companies around the world, from the biggest global consumer brands to governments, technology pioneers, financial services, retailers, and global banks.

Share article on social media or email:

Dr. Micheline Goulart Joins Well-Respected New York Plastic Surgery Practice New You Plastic Surgery


News Image

“I am excited to join New You Plastic Surgery and assist in their mission to make both the functional and aesthetic components of plastic surgery accessible and achievable for any and all patients,” says Dr. Micheline Goulart.

Dr. Micheline Goulart has been recognized across the country for her outstanding work in cosmetic and reconstructive facial plastic surgery as well as breast and body contouring procedures. Dr. Goulart is an enterprising leader of a new generation of plastic surgeons, fusing surgical skills with a sophisticated, open-minded approach to patient care. Originally from Boulder, Colorado, Dr. Goulart completed her integrated plastic surgery residency from The Ohio State University Wexner Medical Center, where she trained under some of the best and most well-known plastic surgeons in the United States and around the world. Prior to joining the elite program there, she trained at the University of Tennessee and graduated cum laude from the University of South Carolina School of Medicine. Having worked and trained across the United States in both urban and rural environments, Dr. Goulart brings an approachable and understanding ethos to her practice. She has spent a considerable amount of time and research in the subspecialty of transgender/gender-affirming plastic surgery and proudly helped found a healthcare advocacy committee in Memphis, TN, to champion for better state healthcare policies. Dr. Goulart especially enjoys performing Mommy Makeover procedures, empowering women to look and feel their best through corrective and aesthetic breast, body and vaginal rejuvenation surgeries. Dr. Goulart holds hospital privileges across the New York metro area and is a member of numerous medical societies.

“I am excited to join New You Plastic Surgery and assist in their mission to make both the functional and aesthetic components of plastic surgery accessible and achievable for any and all patients,” says Dr. Micheline Goulart.

More About New You Plastic Surgery:

New You Plastic Surgery is the practice of board-certified plastic surgeon Dr. Jeremy Nikfarjam. At New You Plastic Surgery, they provide a wide range of cosmetic treatments and plastic surgery procedures to help individuals look their best using cutting-edge surgical techniques for optimal results such as Mommy Makeovers, breast implants, facelifts, rhinoplasty, head-to-toe transformations or reconstructive surgery from an injury. Providing a comfortable and welcoming experience with personalized care, New You Plastic Surgery can also help with financing and payment options.

For more information, please visit http://www.thenewyouplasticsurgery.com and to reach the NYC clinic (461 Park Avenue South, 3rd floor) call 212-843-9170, or for the Great Neck, NY location (800 Northern Boulevard, Unit #6) call 516-279-2616.

Share article on social media or email:

ThingWorx Navigate — Building Better Collaboration with Product Lifecycle Management Data, Upcoming Webinar Hosted by Xtalks


Johnson & Johnson will walk through its: Top collaboration applications, use cases and value; Collaboration architecture vision and roadmap; Best practices for enabling engineering and cross-functional collaboration; And business impact achieved across product quality, revenue and cost savings.

Johnson & Johnson is one of the world’s most admired manufacturers with a strong reputation in medical innovation, health equity and product quality. But with over 130,000 employees and a diverse product portfolio, the pharma company needed better ways of securely collaborating across its global product development teams.

In this webinar, technology leaders in the Johnson & Johnson Medical Device Business Segment will describe how they are using ThingWorx Navigate — a revolutionary new set of apps that lets more stakeholders across a company access and impact product data sourced from multiple systems of record in a simple, role-based interface. This suite of customizable apps can easily access an organization’s product lifecycle management (PLM) data and enable real-time data sharing across development, manufacturing and support to drive better decision-making and innovation.

Johnson & Johnson will walk through its: Top collaboration applications, use cases and value; Collaboration architecture vision and roadmap; Best practices for enabling engineering and cross-functional collaboration; And business impact achieved across product quality, revenue and cost savings.

Join this webinar to learn about building better collaboration with ThingWorx Navigate, a unique software that provides simplified access to PLM data.

Join Preeti Gupta, Lead ThingWorx Architect, Johnson & Johnson; and Emily Larkin, Product Manager, PTC, for the live webinar on Friday, August 26, 2022, at 8am EDT (1pm BST/UK).

For more information, or to register for this event, visit ThingWorx Navigate — Building Better Collaboration with Product Lifecycle Management Data.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

New Documentary Gives Hope to People Suffering from Chronic Diseases


These people share their raw, vulnerable, and remarkable transitions from suffering to health. Today they live vibrant lives, symptom-free, with little or no medication.

DISEASE REVERSAL HOPE! The Film is an inspiring, gripping, and enlightening documentary featuring people who suffered from debilitating, often fatal, chronic diseases: heart, kidney, or liver disease; cancer, diabetes, rheumatoid arthritis, multiple sclerosis, depression, anxiety, obesity, and many other diseases. These people share their raw, vulnerable, and remarkable transitions from suffering to health. Today they live vibrant lives, symptom-free, with little or no medication.

DiseaseReversalHope.org is a non-profit established by Executive Producer Dan Purjes, who with Dr. Scott Stoll, a pioneer in lifestyle medicine, wrote the book DISEASE REVERSAL HOPE! Real People, Real Stories, available on Amazon. This intense film brings the book vividly to life.

The filmmakers, producers, and cast are available for press, podcasts, and interviews.

Press: Media@diseasereversalhope.org

Theatrical release on August 30, 2022, in select theaters, To Be Announced. Pre-sale orders can be taken here.

Share article on social media or email:

ScribeAmerica Announces Top Talent Joining Leadership Team in 2022


“Our new leaders demonstrate our continued investment in our mission to enable healthcare teams to work at top of license and deliver high-quality, cost-effective care to patients,” Dave King, Executive Chairman of ScribeAmerica.

ScribeAmerica, the industry-leading professional provider support and scribe management company, is excited to announce the hiring of top-tier talent to bolster and lead critical functions within the organization.

“These leadership hires reinforce our longstanding commitment to building an exceptional management team with diverse backgrounds and experiences,” said Dave King, Executive Chairman of ScribeAmerica. “Our new leaders demonstrate our continued investment in our mission to enable healthcare teams to work at top of license and deliver high-quality, cost-effective care to patients.”

“The proven talent that we are bringing into the organization positions us to successfully navigate the increasing demand we are experiencing across our full suite of services,” says ScribeAmerica President and Chief Operating Officer Tony Andrulonis. “Their experience will provide additional value as we continue to strategically enhance our offerings that improve efficiency, drive down costs and reduce clinician burnout.”

ScribeAmerica is excited to welcome three outstanding executives: Brian Hudson, Executive Vice President of Sales & Marketing; Marla Sanfilippo, MBA, MHA Senior Vice President of National Accounts; and, David Osborne, Vice President of Talent Acquisition

Brian Hudson will lead our business development team, developing strategies to grow organic new business and to expand our footprint within existing clients. He will work closely with leaders from the nation’s blue chip health systems and provider groups to build deeper relationships and broaden the solutions ScribeAmerica can offer clients.

Brian comes to ScribeAmerica after serving as the Senior Vice President of Sales at Avant Healthcare Professionals. He has also served as Vice President of Sales at Anthelio Healthcare Solutions and as Managing Director at KForce Inc. View Brian Hudson on LinkedIn.

Marla Sanfilippo’s role includes leadership of the overall relationship with Scribe America’s largest national customers, coordinating customer use of the company’s comprehensive suite of services and supporting the overall growth strategies.

Marla’s previous experience includes Vice President roles with Community Psychiatry, Envision Physicians Services, and TeamHealth. She has a track record of success in working collaboratively with various health systems and healthcare leaders throughout the country. View Marla Sanfilippo on LinkedIn.

David Osborne will oversee the identification, recruitment and onboarding of candidates to fill essential company roles nationally. David’s background includes senior management roles with Fortune 500 companies Gannett and HUB International, and a TOP 40 company, Lowe’s. He has led both national and global teams, building out Talent Acquisition organizations and implementing technology to support high-volume recruitment. View David Osborne on LinkedIn.

About ScribeAmerica

For nearly 20 years, ScribeAmerica has been the nation’s largest and most progressive medical scribe company. Serving over 3,500 partners in all 50 states, our dedicated teams custom design, hire, train and manage programs specific to our partners’ needs.

Share article on social media or email:

Morehouse School of Medicine’s “Danforth Dialogues” Podcast Holds A Discussion With EMILY’s List President Laphonza Butler


“Not all of us are going to be marching, but there are roles we can play in educating our communities about the issues that are important to them,” said Ms. Butler.

Morehouse School of Medicine (MSM) today published the latest edition of its new “Danforth Dialogues” podcast, featuring a “Conversation of Significance” between MSM President and CEO Dr. Valerie Montgomery Rice and EMILY’s List President Laphonza Butler discussing the intersection of public health and public policy in this unprecedented period in the history of the United States.

Dr. Montgomery Rice and Ms. Butler, the first Black woman to lead EMILY’s List, held a wide-ranging conversation during the National Medical Association’s (NMA) annual convention here on the continuing health disparities in communities of color in the face of an overarching public health policy debate across the nation’s political landscape.

“As the country continues to deal with the effects of the worst global public health crisis in 100 years, it is important that we reassess our public health policies with an understanding that each person has the right to equitable access to health care, particularly women in underserved communities here and around the world,” said Dr. Montgomery Rice. “We are so pleased to have Ms. Butler, who has dedicated her career to empowering women from all walks of life, join us for this important conversation.”

The podcast was recorded before a live audience of prominent African American female physicians and healthcare leaders at a luncheon hosted by Dr. Montgomery Rice. Ms. Butler and Dr. Montgomery Rice discussed a host of issues including current proposed federal legislation to address the high rate of maternal mortality among Black and Hispanic women.

“Not all of us are going to be marching, but there are roles we can play in educating our communities about the issues that are important to them,” said Ms. Butler. “We wouldn’t be in the position of moving this (maternal health) legislation if not for the quality of research in the academic community.”

Morehouse School of Medicine’s Center for Maternal Health Equity, launched in 2019, has quickly become one of the country’s leading resources to improve maternal health for Black and Hispanic women who are more likely to experience maternal health issues than white women. The Center has received more than $9 million in grants and other funding in support of several research initiatives and programs to improve maternal health in underserved communities.

Launched earlier this year, Danforth Dialogues focuses on the leadership lessons from the frontlines of the COVID-19 pandemic and their broader implication for society. Named after the

historic Danforth Chapel on the Morehouse College campus, the podcast series features a cross-section of guests and topics. The “Conversation of Significance” editions feature more in-depth discussions with key leaders from a wide range of backgrounds. Other editions could include multiple guests and topics not directly related to the pandemic but focused on broader aspects of leadership.

To hear this edition of the podcast, click here. For more information about the Danforth Dialogues leadership series, click here.

To listen and subscribe to the Danforth Dialogues podcast, click here.

For more information about Morehouse School of Medicine, please visit MSM.edu.

###

About Morehouse School of Medicine

  • Founded in 1975, Morehouse School of Medicine (MSM) is among the nation’s leading educators of primary care physicians, biomedical scientists, and public health professionals. An independent and private historically-Black medical school, MSM was recognized by the Annals of Internal Medicine as the nation’s number one medical school in fulfilling a social mission—the creation and advancement of health equity. Morehouse School of Medicine’s faculty and alumni are noted for excellence in teaching, research, and public policy, as well as exceptional patient care. MSM is accredited by the Commission on Colleges of the Southern Association of Colleges and Schools to award doctoral and master’s degrees. To learn more about programs and donate today, please visit http://www.msm.edu or call 404-752-1500.

Share article on social media or email:

Patients Experience Excellent Health Outcomes from Telemedicine


Researchers found that in most cases, care provided by telemedicine had the same or better quality as in-person visits.

Reliable, accurate, and flexible cardiac telemetry is the natural next step for telemedicine. Systems like the MoMe™ ARC Platform allow doctors to achieve the clinical outcomes patients deserve without the technical drawbacks of older telemetry systems.

The COVID-19 pandemic accelerated the use of telemedicine for both routine and acute care. Doctors and patients quickly grew accustomed to videoconferencing and remote monitoring for conditions such as diabetes, respiratory illnesses, and chronic pain. The paradigm shift has boosted demand for better remote healthcare technology to treat a broad range of health conditions. Despite concerns about the efficacy of remote healthcare, evidence shows no downside to telehealth when used appropriately. But current hospital telemetry systems suffer from a lack of portability and adaptability. High-acuity telemetry lacks portability. Portable units lack high acuity.

“The pandemic showed doctors and patients that remote medicine doesn’t result in compromised care,” says Stuart Long, CEO of Infobionic. “The times that telemedicine falls short are when the technology can’t deliver the right information at the right time due to lack of technology to adapt to varying levels of acuity.”

A 2022 study published in the Annals of Internal Medicine reviewed 38 clinical trials from 2013 to 2021 that measured the ability of telehealth to replace or enhance regular patient care. Researchers found that in most cases, care provided by telemedicine had the same or better quality as in-person visits.1

Providers have adopted several types of telehealth:

  • Virtual medical appointments using phone or video chat.
  • Using secure messaging, emails, or patient portals for exchanging information. Technology to remotely track and report bio-feedback has been in use for many years.
  • Use of remote monitoring devices that send feedback to health care providers. Remote cardiac telemetry is used in hospital settings and hospital-to-home situations.

InfoBionic’s MoMe™ ARC Platform* bridges the gap between portability and acuity. It’s an innovative new cloud platform that allows a flexible and modular suite of products to work in concert to capture data in from real-time to near real-time.

Their 3rd generations of products include MoMe(TM) Gateway*, and a suite of innovative Bluetooth® lead sets that allows greater quality, precision & flexibility from low acuity to high acuity in both inpatient and outpatient care settings. The Gateway is the 3rd generation of Bluetooth-enabled technology offered by InfoBionic that’s multicarrier compatible on 4G LTE networks. Along with supporting Bluetooth, the system also supports Wi-Fi connectivity. As part of the MoMe ARC Platform*, the MoMe Gateway* can also allow providers to connect to other qualified third-party Bluetooth devices in addition to the new MoMe K-series Lead Sets.

The Gateway is designed to collect information from three different InfoBionic developed modular Bluetooth lead set systems:

  • The K1, a 5-in-1 pod with a disposable electrode that provides a 1-lead view, 1-channel capability.
  • The K3, a 5-in-1 device featuring 3 electrodes providing a 6-lead view, 2-channel capability.
  • The K7, a 5-in-1 device using 5 electrodes which provides a 7-lead, 3-channel capability.

The MoMe Now* is designed specifically for hospital telemetry to provide step-down level of telemetry for any bed or location that would need an easy to deploy mobile telemetry monitor. Further, it builds on our core expertise to enable a seamless hospital-to-home patient transition where continuous monitoring from real-time to near real-time is essential for meeting the demands of virtual care monitoring.

“Reliable, accurate, and flexible cardiac telemetry is the natural next step for telemedicine,” says Long. “Systems like the MoMe™ ARC Platform* allow doctors to achieve the clinical outcomes patients deserve without the technical drawbacks of older telemetry systems.”

For more information about InfoBionic, visit their website at https://infobionic.com/.

*This product has not been approved by the FDA for sale in the US.

About Infobionic

InfoBionic’s digital technology has transformed the efficiency and economics of cardiac remote patient monitoring. The company’s MoMe™ARC platform has removed the roadblocks hindering remote diagnosis and decision-making. The Massachusetts-based team of seasoned entrepreneurs have had successful careers in healthcare, IT, medical devices, and mobile technology. They bring specific expertise in remote monitoring and cardiology. More recently, working side by side with the healthcare and medical technology communities, including its own competitors, InfoBionic has developed MoMe®Now, the first virtual telemetry system for high-acuity patients in the remote, virtual, or hospital-at-home care environments. Visit https://Infobionic.com

References:

1.    Annals of Internal Medicine. “Video Teleconferencing for Disease Prevention, Diagnosis, and Treatment.” February 2022.

Share article on social media or email:

Scientists Focus on Weed Control to Support Emerging Hemp Market


News Image

“This is our first herbicide residue trial in hemp, and we hope to submit the results to the EPA in 2024,” Roger Batts says. “If approved, it will represent a new tool for weed control in hemp grown for fiber, seed and processed seed commodities like flour and protein-rich hemp hearts.”

Hemp (Cannabis sativa L.) is used to produce a variety of products – from building materials, textiles and paper to nutritious seeds, CBD oils and extracts. Though the crop was introduced in the U.S. centuries ago, scientists with the Weed Science Society of America (WSSA) say much work remains to develop safe and effective approaches to weed control that growers can rely on.

Why the lag? For many decades hemp crops were prohibited by laws and regulations that categorized all varieties of cannabis as controlled substances. The regulatory landscape changed in 2018 when a U.S. Farm Bill authorized hemp as an agricultural product and the Drug Enforcement Agency removed hemp crops with a concentration of no more than 0.3 percent of the psychoactive compound THC from its schedule of controlled substances. The law uses this lower level of THC to distinguish hemp from marijuana.

Despite these changes at the national level, each state retains the authority to establish its own processes for issuing licenses and monitoring hemp production. As a result of these varying regulations and the newness of the revitalized market, experts say weed control tools and protocols for hemp crops have yet to catch up.

“In effect, it’s an old crop that’s brand spanking new,” says Lynn Sosnoskie, Ph.D., an assistant professor at Cornell University and a member of the WSSA board of directors. “Past regulations that banned hemp production also meant a ban on research. As a result, we lack even a basic understanding of how competitive hemp is against weeds.”

With a grant from the U.S. Department of Agriculture, Sosnoskie is working with weed science colleagues at Virginia Tech, Southern Illinois University, North Dakota State University and Clemson University to fill the gap and provide growers with evidence-based, location-specific weed control strategies. Their multistate study will explore the impact of plant varieties, planting times, cultivation, cover crops, mulching and other techniques that may help to keep weeds at bay.

Work is also underway on the herbicide front thanks to the Inter-regional Research Project #4 (IR-4), an organization focused on registration of reduced-risk herbicides, insecticides and fungicides for specialty crops such as hemp.

According to Roger Batts, weed science biologist at IR-4, the organization is conducting screening trials to evaluate the potential effectiveness of existing herbicides that might be used in hemp. Once the best-performing technologies are identified, IR-4 hopes to conduct further performance and/or residue studies needed to support product registration.

One example: An IR-4 residue study is now underway for the postemergence grass herbicide quizalofop. “This is our first herbicide residue trial in hemp, and we hope to submit the results to the Environmental Protection Agency (EPA) in 2024,” Batts says. “If approved, it will represent a new tool for weed control in hemp grown for fiber, seed and processed seed commodities like flour and protein-rich hemp hearts.”

IR-4 has also submitted existing residue data to EPA to support the use of ethalfluralin in hemp. A proven herbicide for the preemergence control of certain annual grasses and broadleaf weeds, the product is already registered for use in industrial hemp in Canada. EPA is expected to publish a tolerance soon for the use of ethalfluralin in hemp grown in the U.S. for fiber and seed.

Want to know more?

A recent IR-4 webinar on hemp is available for replay online. The session covers the production, harvest and uses of industrial hemp, as well as the history of the crop in the United States. Additional information on hemp is also available from the U.S. Hemp Growers Association.

About the Weed Science Society of America

The Weed Science Society of America, a nonprofit scientific society, was founded in 1956 to encourage and promote the development of knowledge concerning weeds and their impact on the environment. The Society promotes research, education and extension outreach activities related to weeds, provides science-based information to the public and policy makers, fosters awareness of weeds and their impact on managed and natural ecosystems, and promotes cooperation among weed science organizations across the nation and around the world. For more information, visit http://www.wssa.net.

Share article on social media or email:

Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC


Dr. Enriqueta Felip, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona, Spain.

“This OS analysis shows a promising trend in favour of atezolizumab over BSC in the PD-L1 TC ≥1%, stage II–IIIA population and a clinically meaningful improvement in the PD-L1 TC ≥50%,” said Dr. Enriqueta Felip.

An interim analysis of overall survival data from the IMpower010 trial showed an overall survival trend in favor of atezolizumab in the PD-L1 TC > 1% stage II-IIIA population (OS HR, 0.71 [95% CI: 0.49, 1.03]), but not in the all randomized stage II-IIIA or intent-to-treat population, according to research presented today at the IASLC World Conference on Lung Cancer 2022 in Vienna.

The highest magnitude of OS improvement was observed in people with stage II-IIIA disease whose tumors expressed PD-L1 TC≥50% (HR=0.43, 95% CI: 0.24-0.78).

IMpower010 previously showed a statistically significant disease-free survival benefit with adjuvant atezolizumab compared with best supportive care in patients with resected non-small cell lung cancer following platinum-based chemotherapy. Based on these findings, atezolizumab was approved as adjuvant treatment after complete resection and platinum-based chemotherapy in patients with programmed death-ligand 1 (PD-L1) tumor cell (TC) ≥1% stage II-IIIA NSCLC in the United States, China, and other countries; and in PD-L1 TC ≥50% stage II-IIIA NSCLC in the European Union (excluding EGFR/ALK+) and other countries

The key secondary overall survival endpoint was not mature at the IMpower010 DFS interim analysis. Today data evaluating overall survival and safety with 13 months of additional follow-up were presented. “With an event to patient ratio of 25% in the ITT population, the OS data are not mature, but are of clinical interest in this curative setting”, said Dr. Enriqueta Felip, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology, Barcelona, Spain.

Eligible patients had completely resected stage IB (tumors ≥4 cm)-IIIA NSCLC (AJCC/UICC v7) and ECOG PS 0-1. Patients received one to four, 21-day cycles of cisplatin-based doublet chemotherapy (enrolment phase) and were subsequently randomized 1:1 to receive 16 cycles of atezolizumab 1200 mg once every three weeks or best supportive care (randomization phase). The primary endpoint was disease-free survival hierarchically tested in 3 prespecified populations ( PD-L1 TC ≥1% stage II-IIIA population, all randomized stage II-IIIA population and ITT population (stage IB-IIIA); secondary endpoints included overall survival among the intent to treat population and safety outcomes. This analysis constitutes the first pre-specified OS IA; OS in the ITT population will only be formally tested if DFS in that population reaches statistical significance at the final DFS analysis.

At the clinical cutoff date (18 April 2022), median follow-up was 45 months and 25% of patients had died (ITT population; N=1005). An overall survival trend in favor of atezolizumab was observed in the PD-L1 TC ≥1% stage II-IIIA population. Adverse events of Grade 3-4 occurred in 22% of the atezolizumab arm and 11.5% of the best supportive care arm and led to atezolizumab discontinuation in 18.2% of patients. Grade 5 treatment-related adverse events occurred in 0.8% of patients who received atezolizumab and 0% in the best supportive care arm. Adverse events of special interest occurred in 52.1% of atezolizumab-treated patients, 7.9% were Grades 3-4.    

“This OS analysis shows a promising trend in favour of atezolizumab over BSC in the PD-L1 TC ≥1%, stage II–IIIA population and a clinically meaningful improvement in the PD-L1 TC ≥50%, stage II–IIIA population, with the OS improvements observed across most subgroups. No separation was observed for the ITT population or the all-randomized, stage II–IIIA populations, and we will continue to follow patients in this study as data mature”, said Dr. Felip, adding that IMpower010 will continue to the final disease-free survival analysis and further overall survival analyses.

About the WCLC:

The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2022.iaslc.org/

Share article on social media or email: